Strategic Wealth Advisors Group, LLC Ionis Pharmaceuticals Inc Transaction History
Strategic Wealth Advisors Group, LLC
- $2.33 Billion
- Q3 2022
A detailed history of Strategic Wealth Advisors Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Strategic Wealth Advisors Group, LLC holds 12,729 shares of IONS stock, worth $501,268. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,729
Previous 12,090
5.29%
Holding current value
$501,268
Previous $445,000
26.52%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$545 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$498 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$406 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$325 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$259 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.59B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...